PaxVax partners with government to develop chikungunya vaccine
by Press Release from Outbreak News Today on (#280T5)
PaxVax announced Thursday its partnership with the National Institutes of Health (NIH) and United States Department of Defense (DoD) on its chikungunya vaccine program. According to the terms of the collaboration, PaxVax has in-licensed the NIH virus-like particle (VLP) vaccine technology for chikungunya with plans to bring the vaccine through full commercialization. NIH has already completed ["]
The post PaxVax partners with government to develop chikungunya vaccine appeared first on Outbreak News Today.